IL6 and neoplasm: As JAK/STAT signaling is activated by both IFN and OSM/IL-6 receptors, it is conceivable that OSM/IL-6 only activates a subset of the IFN-induced genes with tumor-promoting activity, as is the case for Mx1 (81).